Cefotetan

DB01330ApprovedInvestigationalSmall moleculeCephalosporins

Cefotetan is an antibiotic medication used for the prophylaxis and treatment of various bacterial infections, including urinary tract infections, bone and joint infection, and lower respiratory tract infections. A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly.

Chemical structure of Cefotetan
Mechanism
Curator reviewed
Primary indication
For prophylaxis and treatment of bacterial infections.Curator reviewed · 11 structured indications
Formula / weight
C17H17N7O8S4 · 575.619 g/mol (avg)
First approval
Canada, 2003 · United States, 1985
Brand names
  • Cefotan

Resolves to

Compound
UNII48SPP0PA9QCAS69712-56-7ChEMBLCHEMBL474579ChEBI3499PubChem53025KEGGD00260
Clinical / RWD
RxNorm2187ATCJ01DC05PharmGKBPA164784033
Structure
InChIKeySRZNHPXWXCNNDU-IXOPCIAXSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O
Targets
Q75Y35pbp3

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
857Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
11Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
25Marketed productsAcross 3 countries and 9 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cefotetan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In